Epinephrine Auto-Injectors for Infants and Toddlers to Be Available May 1

KFA News Team, April 26, 2018

Epinephrine Auto-Injectors for Infants and Toddlers to Be Available May 1

Kaléo, a privately-held pharmaceutical company, today announced that AUVI-q® (epinephrine injection, USP) 0.1 mg will be available nationwide by prescription beginning May 1, 2018. AUVI-q 0.1 mg is indicated for the treatment of life-threatening allergic reactions, including anaphylaxis, in infants and toddlers weighing 16.5 to 33 pounds (7.5 to 15 kilograms).